BioAffinity Technologies Inc [NASDAQ: BIAF] jumped around 0.0 points on Tuesday, while shares priced at $0.29 at the close of the session, up 2.13%.
BioAffinity Technologies Inc stock is now -88.00% down from its year-to-date (YTD) trading value. BIAF Stock saw the intraday high of $0.3432 and lowest of $0.27 per share. The company’s 52-week high price is 2.99, which means current price is +78.71% above from all time high which was touched on 04/01/25.
Compared to the average trading volume of 7.05M shares, BIAF reached a trading volume of 16604281 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about BioAffinity Technologies Inc [BIAF]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BIAF shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BIAF stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 3.71, with the Price to Cash per share for the same quarter was set at 0.02.
How has BIAF stock performed recently?
BioAffinity Technologies Inc [BIAF] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -12.57. With this latest performance, BIAF shares dropped by -3.97% in over the last four-week period, additionally sinking by -63.84% over the last 6 months – not to mention a drop of -67.81% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BIAF stock in for the last two-week period is set at 49.68, with the RSI for the last a single of trading hit 0.0511, and the three-weeks RSI is set at 0.0550 for BioAffinity Technologies Inc [BIAF]. The present Moving Average for the last 50 days of trading for this stock 0.2778, while it was recorded at 0.3073 for the last single week of trading, and 0.7866 for the last 200 days.
BioAffinity Technologies Inc [BIAF]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and BioAffinity Technologies Inc [BIAF] shares currently have an operating margin of -109.38% and a Gross Margin at 27.48%. BioAffinity Technologies Inc’s Net Margin is presently recorded at -110.55%.
Return on Equity for this stock declined to -143.25%, with Return on Assets sitting at -143.25%.
Insider trade positions for BioAffinity Technologies Inc [BIAF]
There are presently around $1.80%, or 2.38% of BIAF stock, in the hands of institutional investors. The top three institutional holders of BIAF stocks are: VANGUARD GROUP INC with ownership of 0.17 million shares, which is approximately 1.5101%. GEODE CAPITAL MANAGEMENT, LLC, holding 69600.0 shares of the stock with an approximate value of $$0.15 million in BIAF stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$60232.0 in BIAF stock with ownership which is approximately 0.2448%.
